Search Results

Return to List
Results 1–15 of 15
Sort By: Relevance | Date | Title
1.

Amnioinfusion Does Not Prevent Meconium Aspiration Syndrome

Committee Opinion Number 346, October 2006

(Reaffirmed 2016)

ABSTRACT Amnioinfusion has been advocated as a technique to reduce the incidence of meconium aspiration and to improve neonatal outcome However a large proportion of women with meconiumstained amniotic fluid have infants who have taken in meconium within the trachea or bronchioles before meconium ...

October 2006

PDF Format
2.

Antenatal Corticosteroid Therapy for Fetal Maturation

Committee Opinion Number 677, October 2016

ABSTRACT Corticosteroid administration before anticipated preterm birth is one of the most important antenatal therapies available to improve newborn outcomes A single course of corticosteroids is recommended for pregnant women between 24 07 weeks and 33 67 weeks of gestation including for those w...

October 2016

PDF Format
3.

Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period

Committee Opinion Number 623, February 2015

(Reaffirmed 2016. Replaces Committee Opinion Number 514, December 2011)

ABSTRACT Acuteonset severe systolic hypertension severe diastolic hypertension or both can occur in pregnant women or women in the postpartum period Introducing standardized evidencebased clinical guidelines for the management of patients with preeclampsia and eclampsia has been demonstrated to re...

February 2015

PDF Format
4.

Hospital-Based Triage of Obstetric Patients

Committee Opinion Number 667, July 2016

ABSTRACT Emergency departments typically have structured triage guidelines for health care providers encountering the diverse cases that may present to their units Such guidelines aid in determining which patients must be evaluated promptly and which may wait safely and aid in determining anticipa...

July 2016

PDF Format
5.

Immediate Postpartum Long-Acting Reversible Contraception

Committee Opinion Number 670, August 2016

ABSTRACT Immediate postpartum longacting reversible contraception LARC has the potential to reduce unintended and shortinterval pregnancy Women should be counseled about all forms of postpartum contraception in a context that allows informed decision making Immediate postpartum LARC should be offe...

August 2016

PDF Format
6.

Lead Screening During Pregnancy and Lactation

Committee Opinion Number 533, August 2012

(Reaffirmed 2016)

Abstract Prenatal lead exposure has known adverse effects on maternal health and infant outcomes across a wide range of maternal blood lead levels Adverse effects of lead exposure are being identified at lower levels of exposure than previously recognized in both children and adults In 2010 the Ce...

August 2012

PDF Format
7.

Magnesium Sulfate Before Anticipated Preterm Birth for Neuroprotection

Committee Opinion Number 455, March 2010

Reaffirmed 2015

Abstract Numerous large clinical studies have evaluated the evidence regarding magnesium sulfate neuroprotection and preterm births The Committee on Obstetric Practice and the Society for MaternalFetal Medicine recognize that none of the individual studies found a benefit with regard to their prim...

March 2010

PDF Format
8.

Magnesium Sulfate Use in Obstetrics

Committee Opinion Number 652, January 2016

(Reaffirmed 2016. Replaces Committee Opinion Number 573, September 2013)

ABSTRACT The US Food and Drug Administration advises against the use of magnesium sulfate injections for more than 57 days to stop preterm labor in pregnant women Based on this the drug classification was changed from Category A to Category D and the labeling was changed to include this new warnin...

January 2016

PDF Format
9.

Maternal-Fetal Intervention and Fetal Care Centers

Committee Opinion Number 501, August 2011

(Reaffirmed 2014)

ABSTRACT The past two decades have yielded profound advances in the fields of prenatal diagnosis and fetal intervention Although fetal interventions are driven by a beneficencebased motivation to improve fetal and neonatal outcomes advancement in fetal therapies raises ethical issues surrounding m...

August 2011

PDF Format
10.

Medically Indicated Late-Preterm and Early-Term Deliveries

Committee Opinion Number 560, April 2013

(Reaffirmed 2015)

ABSTRACT The neonatal risks of late preterm 34 0736 67 weeks of gestation and earlyterm 37 0738 67 weeks of gestation births are well established However there are a number of maternal fetal and placental complications in which either a latepreterm or earlyterm delivery is warranted The timing of ...

April 2013

PDF Format
11.

Nonmedically Indicated Early-Term Deliveries

Committee Opinion Number 561, April 2013

(Reaffirmed 2015)

ABSTRACT For certain medical conditions available data and expert opinion support optimal timing of delivery in the latepreterm or earlyterm period for improved neonatal and infant outcomes However for nonmedically indicated earlyterm deliveries such an improvement has not been demonstrated Morbid...

April 2013

PDF Format
12.

Optimizing Postpartum Care

Committee Opinion Number 666, June 2016

ABSTRACT In the weeks after birth postpartum care often is fragmented among maternal and pediatric health care providers and communication between inpatient and outpatient settings is inconsistent To optimize postpartum care anticipatory guidance should begin during pregnancy During antenatal care...

June 2016

PDF Format
13.

Placenta Accreta

Committee Opinion Number 529, July 2012

Reaffirmed 2015

ABSTRACT Placenta accreta is a potentially lifethreatening obstetric condition that requires a multidisciplinary approach to management The incidence of placenta accreta has increased and seems to parallel the increasing cesarean delivery rate Women at greatest risk of placenta accreta are those w...

July 2012

PDF Format
14.

Prevention of Early-Onset Group B Streptococcal Disease in Newborns

Committee Opinion Number 485, April 2011

(Replaces No. 279, December 2002, Reaffirmed 2015)

ABSTRACT In 2010 the Centers for Disease Control and Prevention revised its guidelines for the prevention of perinatal group B streptococcal disease Although universal screening at 3537 weeks of gestation and intrapartum antibiotic prophylaxis continue to be the basis of the prevention strategy th...

April 2011

PDF Format
15.

The Apgar Score

Committee Opinion Number 644, October 2015

(Replaces Committee Opinion Number 333, May 2006)

ABSTRACT The Apgar score provides an accepted and convenient method for reporting the status of the newborn infant immediately after birth and the response to resuscitation if needed The Apgar score alone cannot be considered to be evidence of or a consequence of asphyxia does not predict individu...

October 2015

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998